China Meheco Group CoSHSE:600056 -2.53%64 Operating Margin % is 4.19% as of Mar. 2026, which is 27% below its 10-year median of 5.74. GuruFocus rates SHSE:600056 with a GF Score™ of 64/100 and a GF Value™ of ¥10.49 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, China Meheco Group Co ranks better than 63.03% on this metric.
China Meheco Group Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -12.6%.
The historical rank and industry rank for China Meheco Group Co's Operating Margin % or its related term are showing as below:
SHSE:600056'
s Operating Margin % Range Over the Past 10 Years
Min: 3.91 Med: 5.74 Max: 8.46
Current: 4.03
SHSE:600056's Operating Margin % is ranked better than 63.03% of 119
companies
in the Medical Distribution industry
Industry Median: 3.07
vs SHSE:600056: 4.03
China Meheco Group Co's 5-Year Average Operating Margin % Growth Rate was -12.60% per year.
China Meheco Group Co (SHSE:600056) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
China Meheco Group Co Operating Margin % Related Terms
China Meheco Group Co Operating Margin % Historical Data
* Premium members only.
The historical data trend for China Meheco Group Co's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600056 vs MCK, COR, CAH: Operating Margin % Comparison
For the Medical Distribution subindustry, China Meheco Group Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Meheco Group Co Operating Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where China Meheco Group Co's Operating Margin % falls into.
China Meheco Group Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
China Meheco Group Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Meheco Group Co (SHSE:600056) has a Operating Margin % of 4.19% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on China Meheco Group Co and its competitors. This is 27% below median its historical median of 5.74. Over the past decade, China Meheco Group Co's Operating Margin % has ranged from 3.91 to 8.46. According to the industry distribution chart, China Meheco Group Co ranks #44 out of 119 companies in the Medical Distribution industry, placing it in the top 37%.
Is China Meheco Group Co's Operating Margin % too high?
China Meheco Group Co's current Operating Margin % of 4.19% is 27% below median its 10-year median of 5.74. Over the past 10 years, this metric has ranged from a low of 3.91 to a high of 8.46. The Medical Distribution industry median Operating Margin % is 3.07. China Meheco Group Co's value of 4.19% is 36.5% above this industry median. Based on the distribution chart, China Meheco Group Co ranks #44 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, China Meheco Group Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China Meheco Group Co's Operating Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China Meheco Group Co ranks #44 out of 119 companies for Operating Margin %. This puts China Meheco Group Co in the upper half of its industry. The industry median Operating Margin % is 3.07. China Meheco Group Co's value of 4.19% is 36.5% above this benchmark. Historically, China Meheco Group Co's own Operating Margin % has ranged from 3.91 to 8.46 over the past decade. While the company's 10-year median is 5.74 vs. the industry median of 3.07, China Meheco Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Distribution company?
The median Operating Margin % among Medical Distribution companies is 3.07, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Meheco Group Co's current Operating Margin % of 4.19% is 36.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on China Meheco Group Co and its competitors. For the Medical Distribution industry, the median Operating Margin % is 3.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Meheco Group Co's current Operating Margin % is 4.19%, which is 27% below median its own 10-year median of 5.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Meheco Group Co stock overvalued right now?
Based on GuruFocus' analysis, China Meheco Group Co (SHSE:600056) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.49, compared to a current price of ¥8.87 — trading 15.4% below its estimated fair value. The current Operating Margin % is 4.19%, which is 27% below median its 10-year median of 5.74 and 36.5% above the Medical Distribution industry median of 3.07. China Meheco Group Co's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For China Meheco Group Co (SHSE:600056), the current Operating Margin % is 4.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Meheco Group Co (SHSE:600056) Overvalued in 2026?
Based on GuruFocus' analysis, China Meheco Group Co stock appears to be undervalued.
The current stock price of ¥8.87 is trading 15.4% below its estimated GF Value™ of ¥10.49.
GuruFocus considers China Meheco Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:600056:
Operating Margin %: 4.19% (27% below median its 10-year median of 5.74)
GF Value™: ¥10.49 vs. price of ¥8.87 (15.4% below fair value)
Industry Position: 36.5% above the Medical Distribution median (#44 of 119)
No single metric tells the full story. See the SHSE:600056 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, and Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, and logistics to international trading, academic promotion, and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products, and others.
64GF Score
Get the complete analysis for SHSE:600056
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600056 has been successfully added to your 
